Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen M Holtz

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|April 10, 2003
Lithium chloride inactivates the 20S proteasome from WEHI-3B D+ leukemia cellsKathleen M Holtz, Anna M Rice, Alan C Sartorelli
The Journal of Biological Chemistry|November 9, 2002
Nuclear overexpression of NADH:cytochrome b5 reductase activity increases the cytotoxicity of mitomycin C (MC) and the total number of MC-DNA adducts in Chinese hamster ovary cellsKathleen M Holtz, Sara Rockwell, Maria Tomasz, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 26, 2005
Structure of the wild-type TEM-1 beta-lactamase at 1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzymeBoguslaw Stec, Kathleen M Holtz, Cheryl L Wojciechowski, et al.
Leukemia Research|September 24, 2004
Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemiaAnna M Rice, Kathleen M Holtz, Judith Karp, et al.
Vaccine|November 29, 2005
Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccineKeyang Wang, Kathleen M Holtz, Karl Anderson, et al.
Journal of Pharmaceutical Sciences|January 16, 2014
Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storageJohn M Hickey, Kathleen M Holtz, Prakash Manikwar, et al.
BMC Biotechnology|December 26, 2014
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency lossKathleen M Holtz, Pamela S Robinson, Erin E Matthews, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|April 10, 2003
Lithium chloride inactivates the 20S proteasome from WEHI-3B D+ leukemia cellsKathleen M Holtz, Anna M Rice, Alan C Sartorelli
The Journal of Biological Chemistry|November 9, 2002
Nuclear overexpression of NADH:cytochrome b5 reductase activity increases the cytotoxicity of mitomycin C (MC) and the total number of MC-DNA adducts in Chinese hamster ovary cellsKathleen M Holtz, Sara Rockwell, Maria Tomasz, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 26, 2005
Structure of the wild-type TEM-1 beta-lactamase at 1.55 A and the mutant enzyme Ser70Ala at 2.1 A suggest the mode of noncovalent catalysis for the mutant enzymeBoguslaw Stec, Kathleen M Holtz, Cheryl L Wojciechowski, et al.
Leukemia Research|September 24, 2004
Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemiaAnna M Rice, Kathleen M Holtz, Judith Karp, et al.
Vaccine|November 29, 2005
Expression and purification of an influenza hemagglutinin--one step closer to a recombinant protein-based influenza vaccineKeyang Wang, Kathleen M Holtz, Karl Anderson, et al.
Journal of Pharmaceutical Sciences|January 16, 2014
Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storageJohn M Hickey, Kathleen M Holtz, Prakash Manikwar, et al.
BMC Biotechnology|December 26, 2014
Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency lossKathleen M Holtz, Pamela S Robinson, Erin E Matthews, et al.
Pageof 1